Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional)
ID: 336829Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/336829

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAS-22-074.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) grant, aimed at promoting innovative interdisciplinary research in benign urologic conditions, with a current focus on neurourology. This program invites R01 grant applications for basic, translational, and clinical research that addresses neural mechanisms contributing to urologic diseases, emphasizing the importance of collaboration among diverse research teams, including early-stage investigators. The NIH has allocated an annual budget of $1,125,000 for approximately three awards per fiscal year, with applications accepted until May 7, 2025. Interested applicants can find more information and guidelines at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAS-22-074-Full-Announcement.html
    PAS-22-074.html
    The Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) program, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), aims to foster innovative and interdisciplinary research addressing benign urologic conditions, focusing specifically on neurourology. This program invites R01 grant applications for studies spanning basic, translational, and clinical research, especially on neural mechanisms contributing to urologic diseases. Key dates for application submissions span from February 2022 through February 2025, with an annual budget of $1,125,000 designated for approximately three awards per fiscal year. Eligible applicants include diverse educational institutions, non-profits, for-profit organizations, and government entities, emphasizing collaboration among interdisciplinary teams and the participation of early-stage investigators. The applications must adhere strictly to stipulated guidelines, covering aspects like research strategy, budget justification, and inclusion plans for diverse populations. This grant aims to close knowledge gaps in urologic diseases, thus promoting better prevention, diagnosis, and treatment strategies, contributing to improved patient outcomes. The focus on multifaceted research approaches underscores the NIDDK’s commitment to addressing complex health issues in urology.
    Similar Opportunities
    Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Institutional Network Award (U2C) to enhance training in kidney, urologic, and hematologic research. This funding opportunity aims to foster a collaborative environment by inviting institutions to submit a unified application that supports a cohort of trainees and early-career investigators, with a strong emphasis on partnerships among institutions within metropolitan areas. The initiative is crucial for reshaping research training and promoting scientific collaboration, ensuring that the next generation of researchers is equipped to address complex biomedical challenges. Applications will be accepted starting October 16, 2023, with a submission deadline of September 27, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional)" aimed at advancing clinical research in the field of substance use disorders (SUD). The primary objective is to identify and validate novel targets for non-invasive brain stimulation (NIBS) and to explore the neurobiological, cognitive, and behavioral responses associated with NIBS that may lead to improved clinical outcomes such as reduced cravings or drug use. This initiative is crucial for enhancing understanding and treatment options for SUD through innovative research methodologies. Funding of up to $1.5 million is available for selected projects over a maximum project period of five years, with applications due by August 14, 2026. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the detailed application instructions available at the provided link.
    Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)" aimed at accelerating the development of medications for Substance Use Disorders (SUDs). This initiative encourages research applications that support a diverse range of preclinical and clinical projects, with the goal of advancing medication studies toward FDA approval, emphasizing the importance of innovative approaches to drug misuse and addiction treatment. Eligible applicants include a variety of institutions, such as higher education entities and community organizations, with funding available up to $5 million per year for projects lasting up to three years. Interested parties can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by August 11, 2025.
    NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Sustainable Transformation of Institutional Research Rigor (STIRR) Program, a federal grant opportunity aimed at enhancing research rigor and transparency within academic and research institutions in the field of neuroscience. This initiative seeks to support innovative programs and strategies that promote high-quality research practices, emphasizing rigorous study design and transparent reporting to foster a culture of scientific integrity. The NIH plans to allocate approximately $3.5 million annually for up to five awards, with individual grants ranging from $150,000 to $800,000 over a three-year period. Interested applicants must submit their proposals by October 17, 2025, and can find additional information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Biology of Bladder Cancer (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for research into the biology of bladder cancer through the R21 Clinical Trial Optional grant program. This initiative aims to support applications that investigate the molecular mechanisms and biological processes underlying bladder cancer, a significant health issue due to its high incidence and recurrence rates. The program encourages multidisciplinary research that utilizes clinical specimens and explores both normal and cancerous bladder processes, with a funding ceiling of $275,000 available over a two-year period. Interested applicants, including various educational and community organizations, must submit their proposals by September 7, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for investigator-initiated, high-risk multi-center clinical trials through the Notice of Funding Opportunity (NOFO) PA-25-147. This cooperative agreement (U01) aims to support innovative studies that address critical health issues related to diabetes, digestive diseases, and kidney conditions, requiring proposals to be hypothesis-driven and operationally classified as high-risk. The program emphasizes the importance of diverse perspectives in research and mandates that planning activities be completed prior to application submission. Interested applicants should note that the application period opens on January 3, 2025, with a submission deadline of November 5, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Neurological Disorders and Stroke (NINDS), is offering a funding opportunity for investigator-initiated exploratory clinical trials under the UG3/UH3 mechanism. This initiative aims to support Phase 1 and Phase 2 clinical trials that address critical questions related to neurological disorders, focusing on studies involving drugs, biologics, devices, and early interventions. The program emphasizes rigorous research design and encourages diverse and innovative research teams, with grants potentially spanning up to five years, beginning with a planning phase before transitioning to execution. Interested applicants can find more information and application details at the provided link, with a submission deadline of March 10, 2025, and no cost-sharing or matching requirement.
    NIH Research Project Grant (Parent R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIH Research Project Grant, designated as the Parent R01 Clinical Trial Required (Funding Opportunity Number PA-25-305). This grant supports discrete research projects that include at least one clinical trial and align with the scientific missions of participating NIH Institutes and Centers. The initiative aims to foster innovative health-related research and enhance scientific resources, with applications accepted from a diverse range of organizations, including higher education institutions and community-based organizations. Applications will open on January 5, 2025, with subsequent submission deadlines throughout 2025 and 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Biology of Bladder Cancer (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Biology of Bladder Cancer (R01 Clinical Trial Optional)" aimed at advancing research into the biological mechanisms underlying bladder cancer. This initiative seeks applications that investigate various aspects of bladder cancer, including its initiation, progression, and the molecular changes associated with the disease, with a focus on enhancing understanding to develop new interventions. Given the significant health burden posed by bladder cancer, characterized by high incidence and recurrence rates, this research is crucial for improving survival rates and addressing disparities in outcomes among different populations. Eligible applicants include a wide range of institutions and organizations, with no budget limit for projects that can last up to five years. Interested parties can find more information and application guidelines at the NIH website, and the application deadline is September 7, 2025. For inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required), aimed at supporting multi-center clinical trials focused on neurological emergencies such as status epilepticus and traumatic brain injury. This initiative encourages collaboration with the NIH SIREN Clinical Coordinating Center to ensure efficient trial implementation, while applicants are expected to provide rigorous preclinical data and compelling rationales for their proposed interventions. The funding opportunity operates under a phased mechanism, with UG3 for planning and UH3 for execution, reflecting a commitment to enhance clinical research in emergency care. Interested applicants can find more information and application guidelines at the provided link, with a submission deadline of March 6, 2026, and no cost-sharing or matching requirements.